CD79A and infection: In vivo, ADCP was also associated with a reduced risk of infection in SIV (24) and SHIV (25) infection of NHPs, although the route of immunization, the type of effector phagocyte and the isotype, namely IgG or IgA, were associated with different ADCP outcomes (24).